Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

141.

Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.

Cell.
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA.
| Dec 19, 2013
142.

Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.

Proc. Natl. Acad. Sci. U.S.A.
Choi YI, Duke-Cohan JS, Chen W, Liu B, Rossy J, Tabarin T, Ju L, Gui J, Gaus K, Zhu C, Reinherz EL.
| Jan 7, 2014
143.

Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Proc. Natl. Acad. Sci. U.S.A.
Holderried TA, Lang PA, Kim HJ, Cantor H.
| Dec 24, 2013
144.

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.

Science.
Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin WG.
| Jan 17, 2014
145.

Inconsistency in large pharmacogenomic studies.

Nature.
Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, Beck AH, Aerts HJ, Quackenbush J.
| Dec 19, 2013
146.

A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.

Cell.
Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A, Price E, Liu M, Barton ER, Kahn CR, Wagers AJ, Zon LI.
| Nov 7, 2013
147.

Lin28 enhances tissue repair by reprogramming cellular metabolism.

Cell.
Shyh-Chang N, Zhu H, Yvanka de Soysa T, Shinoda G, Seligson MT, Tsanov KM, Nguyen L, Asara JM, Cantley LC, Daley GQ.
| Nov 7, 2013
148.

The quest to overcome resistance to EGFR-targeted therapies in cancer.

Nat. Med.
Chong CR, Jänne PA.
| 11 07, 2013
149.

Development. A stem cell perspective on cellular engineering.

Science.
Doulatov S, Daley GQ.
| Nov 8, 2013
150.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Nat. Genet.
Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.
| 11 03, 2013
151.

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.

Nature.
Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, Garraway LA.
| Dec 5, 2013
152.

Cancer-drug discovery and cardiovascular surveillance.

N. Engl. J. Med.
Groarke JD, Cheng S, Moslehi J.
| Nov 7, 2013
153.

Linking the SWI/SNF complex to prostate cancer.

Nat. Genet.
Lee RS, Roberts CW.
| 10 30, 2013
154.

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J, Mendez G.
| Jan 4, 2014
155.

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.

Proc. Natl. Acad. Sci. U.S.A.
Johnson N, Johnson SF, Yao W, Li YC, Choi YE, Bernhardy AJ, Wang Y, Capelletti M, Sarosiek KA, Moreau LA, Chowdhury D, Wickramanayake A, Harrell MI, Liu JF, D'Andrea AD, Miron A, Swisher EM, Shapiro GI.
| Oct 15, 2013
156.

Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.

Nat. Med.
Gruber Filbin M, Dabral SK, Pazyra-Murphy MF, Ramkissoon S, Kung AL, Pak E, Chung J, Theisen MA, Sun Y, Franchetti Y, Sun Y, Shulman DS, Redjal N, Tabak B, Beroukhim R, Wang Q, Zhao J, Dorsch M, Buonamici S, Ligon KL, Kelleher JF, Segal RA.
| 09 29, 2013
157.

Pan-cancer patterns of somatic copy number alteration.

Nat. Genet.
Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhang CZ, Wala J, Mermel CH, Sougnez C, Gabriel SB, Hernandez B, Shen H, Laird PW, Getz G, Meyerson M, Beroukhim R.
| Sep 26, 2013
158.

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

N. Engl. J. Med.
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M, Marty F.
| Sep 26, 2013
159.

Long-term colorectal-cancer incidence and mortality after lower endoscopy.

N. Engl. J. Med.
Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S, Chan AT.
| Sep 19, 2013